According to Zacks, “DSM N V ADR is involved in the Chemicals Industry. Their main focus is on base materials, performance materials, materials processing, base chemicals and fine chemicals and coating resins. They are also involved in the exploration and development of oil and natural gas deposits in the North Sea, as well as the licensing of chemical technology and know-how; in addition the company produces ingredients for bakery products. DSM is a world market leader in a number of products, including caprolactam, melamine and EPDM synthetic rubber. “
A number of other equities analysts also recently commented on the stock. ABN Amro downgraded shares of Koninklijke DSM from a buy rating to a hold rating in a report on Monday, August 5th. ValuEngine downgraded shares of Koninklijke DSM from a buy rating to a hold rating in a report on Thursday, August 1st. Finally, JPMorgan Chase & Co. upgraded shares of Koninklijke DSM from a neutral rating to an overweight rating in a report on Friday, July 5th. Three research analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Koninklijke DSM has a consensus rating of Buy and an average target price of $30.00.
Shares of Koninklijke DSM stock opened at $31.60 on Friday. The company has a market capitalization of $22.80 billion, a P/E ratio of 18.27, a PEG ratio of 3.78 and a beta of 1.39. The company has a debt-to-equity ratio of 0.29, a current ratio of 2.45 and a quick ratio of 1.68. The business has a 50-day moving average price of $31.34. Koninklijke DSM has a one year low of $19.45 and a one year high of $32.25.
About Koninklijke DSM
Koninklijke DSM N.V., a science-based company, engages in nutrition, health, and materials businesses in the Netherlands, North America, the United Kingdom, France, Germany, Switzerland, the Asia-Pacific, and internationally.. The company operates through Nutrition, Materials, and Innovation Center segments.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Koninklijke DSM Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke DSM and related companies with MarketBeat.com's FREE daily email newsletter.